Most Read Articles
one year ago
Temozolomide is effective and well-tolerated as treatment of aggressive pituitary tumours, a study revealed.
Pearl Toh, 18 days ago
Data from the first whole genome sequencing in a large group of long-term childhood cancer survivors enrolled in the St. Jude Lifetime Cohort Study revealed that 12 percent of childhood cancer survivors have germline mutations in genes known to predispose them to cancers and subsequent neoplasms.
Tristan Manalac, 6 days ago
Women with higher age at breast cancer diagnosis and Indian women are at a higher risk of cardiovascular disease (CVD) mortality after diagnosis, a new prospective cohort study shows. However, risk of CVD mortality within 10 years after diagnosis remains low in Southeast Asia.
Jenny Ng, 2 years ago

The WHO’s 2014 World Cancer Report predicts a crisis in cancer over the next 20 years, with a 75 percent surge in cases worldwide from 2008 and a projected economic cost totalling USD 1 trillion. 

Neoadjuvant Treatment of Early Breast Cancer

2 months ago
Over 20 leading surgical and medical oncologists from Singapore attended a dinner meeting on the Neoadjuvant treatment of early breast cancer (eBC). Co-chaired by Dr Veronique Tan (National Cancer Centre, Singapore) and Dr Elaine Lim (National Cancer Centre, Singapore), the meeting served as a platform to discuss the role of neoadjuvant therapy in eBC management. Guest speakers, Professor J. Michael Dixon OBE (Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom) and Dr Rebecca Dent (National Cancer Centre, Singapore) shared their perspectives on the benefits of neoadjuvant therapy in different BC subtypes.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
one year ago
Temozolomide is effective and well-tolerated as treatment of aggressive pituitary tumours, a study revealed.
Pearl Toh, 18 days ago
Data from the first whole genome sequencing in a large group of long-term childhood cancer survivors enrolled in the St. Jude Lifetime Cohort Study revealed that 12 percent of childhood cancer survivors have germline mutations in genes known to predispose them to cancers and subsequent neoplasms.
Tristan Manalac, 6 days ago
Women with higher age at breast cancer diagnosis and Indian women are at a higher risk of cardiovascular disease (CVD) mortality after diagnosis, a new prospective cohort study shows. However, risk of CVD mortality within 10 years after diagnosis remains low in Southeast Asia.
Jenny Ng, 2 years ago

The WHO’s 2014 World Cancer Report predicts a crisis in cancer over the next 20 years, with a 75 percent surge in cases worldwide from 2008 and a projected economic cost totalling USD 1 trillion.